Learn / TARS
NASDAQ: TARS
Tarsus Pharmaceuticals (TARS) stock, explained like you're 5
Tarsus Pharmaceuticals trades on the Nasdaq under the ticker TARS. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 3.4 billion dollars.
- Ticker
- TARS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 3.4 billion dollars
Is Tarsus Pharmaceuticals a small, medium or large cap company?
No. Tarsus Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.4 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Tarsus Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves TARS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Tarsus Pharmaceuticals, Inc. (TARS) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Tarsus Pharmaceuticals (TARS) Could Be 32% Undervalued After New Shelf Registrations (Simply Wall Street)
- Tarsus Pharmaceuticals (TARS) Selling Stockholders Plan to Offlo (GuruFocus)
- Liquidity Mapping Around (TARS) Price Events (Stock Traders Daily)
- Tarsus Pharmaceuticals: XDEMVY Now Pays The Bills, And The Retina Deals Work Like Options (Seeking Alpha)
Follow TARS in your daily brief
Each trading day at 5 PM ET we post what happened to Tarsus Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow TARS
Questions about Tarsus Pharmaceuticals stock
What does Tarsus Pharmaceuticals do?
Tarsus Pharmaceuticals trades on the Nasdaq under the ticker TARS. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 3.4 billion dollars.
What is the ticker symbol for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals trades under the ticker TARS on the Nasdaq.
What is Tarsus Pharmaceuticals's market cap?
Tarsus Pharmaceuticals is a mid cap stock with a market cap of about 3.4 billion dollars.
How does Tarsus Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves TARS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow TARS stock every day?
Add TARS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.